Conexeu Sciences is trading at $2.78, with a -5.76% change; no clear cause has been established for the October 28 decline.
- The company disclosed an inducement program for up to 4,762,780 existing warrants, offering one new warrant for each exercised, with a $3.00 exercise price.
- The Reuters-listed announcement is current, but available coverage does not establish it caused the decline. Biotech is up 2.18%, while major indexes are mixed.